Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc., USA | Monroe, NC, United States | Makes it and tests it | Problems found, fixed voluntarilyJun 17, 2025 · 2 inspections, 1 with FDA action |
| Glenmark Pharmaceuticals Limited | Goa, India | Makes it and tests it | Problems found, fixed voluntarilyJun 30, 2026 · 7 inspections, 1 with FDA action |
Recalls
- Apr 25, 2022 · Class II · Glenmark Pharmaceuticals Inc., USA
cGMP deviations
Lots: Lot #: 29200052, Exp 4/30/2023 - Apr 25, 2022 · Class II · Glenmark Pharmaceuticals Inc., USA
cGMP deviations
Lots: Lot #: 29200064, Exp 5/31/2023 - Apr 25, 2022 · Class II · Glenmark Pharmaceuticals Inc., USA
cGMP deviations
Lots: a) Lot #: 29200053, Exp 4/30/2023; b) Lot #: 29200054, Exp 4/30/2023 - Aug 27, 2021 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lots: 29190043 Exp. 05/31/2022; 29190044 Exp. 05/31/2022; 29190045 Exp. 05/31/2022 - Aug 27, 2021 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lots: a) 29200014 Exp. 02/28/2023; 29200015 Exp. 03/31/2023; 29200016 Exp. 03/31/2023; 29200030 Exp. 05/31/2023; 29200031 Exp. 05/31/2023; 29200032 Exp. 05/31/2023; 29200033 Exp. 06/30/2023; 29200037 Exp. 06/30/2023; 29200038 Exp. 06/30/2023; 29200039 Exp. 07/31/2023; 29200041 Exp. 07/31/2023; 2920…
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Zonisamide: every company that makes it
- Form
- capsule, oral
- Strength
- 100 mg
- Approval
- ANDA ANDA077651
- On the market since
- Jan 30, 2006
- Package NDCs
68462-130-0168462-130-05- Official label
- DailyMed (National Library of Medicine), updated Oct 27, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?